diaziquone has been researched along with Neuroectodermal Tumors, Primitive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kees, UR; Sterling-Levis, K; Tobias, V; White, L | 1 |
1 other study(ies) available for diaziquone and Neuroectodermal Tumors, Primitive
Article | Year |
---|---|
Medulloblastoma/primitive neuroectodermal tumour studied as a Matrigel enhanced subcutaneous xenograft model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Aziridines; Benzoquinones; Biocompatible Materials; Carboplatin; Cerebellar Neoplasms; Cisplatin; Collagen; Cyclophosphamide; Drug Combinations; Immunophenotyping; Laminin; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neuroectodermal Tumors, Primitive; Proteoglycans; Treatment Outcome; Vincristine; Xenograft Model Antitumor Assays | 2001 |